| Feb 27, 2026 |
Mar 3, 2026 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Makunje Moses
|
Officer |
Neutral |
90.0
|
+50,761
|
292.13%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Wentworth Kerry
|
CHIEF REGULATORY OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Sjogren Colleen
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Sauvage Philippe
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Markel Stacy
|
CHIEF PEOPLE OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Cui Xiangmin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Hattersley Gary
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Hanley David C.
|
CHIEF TECHNICAL OPERATIONS |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2026 |
Mar 3, 2026 |
Hung David
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 1, 2025 |
Dec 3, 2025 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Sell |
17.5
|
-150,000
|
-89.29%
|
✗
|
$1.2M |
| Nov 25, 2025 |
Nov 26, 2025 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Sell |
22.5
|
-20,000
|
-35.71%
|
✗
|
$155K |
| Nov 20, 2025 |
Nov 24, 2025 |
Hattersley Gary
|
CHIEF SCIENTIFIC OFFICER |
Sell |
17.5
|
-369,051
|
-100.00%
|
✗
|
$2.7M |
| Nov 20, 2025 |
Nov 24, 2025 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Sell |
22.5
|
-20,000
|
-52.63%
|
✗
|
$140.1K |
| Nov 19, 2025 |
Nov 21, 2025 |
Hanley David C.
|
CHIEF TECHNICAL OPERATIONS |
Sell |
17.5
|
-200,000
|
-89.29%
|
✗
|
$1.4M |
| Nov 17, 2025 |
Nov 19, 2025 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Sell |
22.5
|
-30,000
|
-47.62%
|
✗
|
$148K |
| Oct 27, 2025 |
Oct 29, 2025 |
Hattersley Gary
|
CHIEF SCIENTIFIC OFFICER |
Sell |
7.5
|
-100,000
|
-100.00%
|
✓
|
$502.5K |
| Aug 11, 2025 |
Aug 13, 2025 |
Mashal Robert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 18, 2025 |
Markel Stacy
|
CHIEF PEOPLE OFFICER |
Buy |
91.3
|
+10,000
|
51.04%
|
✗
|
$17.1K |
| Jun 16, 2025 |
Jun 18, 2025 |
Sauvage Philippe
|
CFO |
Buy |
91.3
|
+7,300
|
280.55%
|
✗
|
$13.2K |
| Jun 16, 2025 |
Jun 18, 2025 |
Sjogren Colleen
|
Chief Commercial Officer |
Buy |
95.0
|
+50,000
|
161.29%
|
✗
|
$90.4K |
| Jun 16, 2025 |
Jun 18, 2025 |
Wentworth Kerry
|
CHIEF REGULATORY OFFICER |
Buy |
95.0
|
+50,000
|
100.00%
|
✗
|
$89.7K |
| Jun 16, 2025 |
Jun 18, 2025 |
Hung David
|
CEO |
Buy |
75.0
|
+500,000
|
0.85%
|
✗
|
$893.5K |
| May 21, 2025 |
May 23, 2025 |
FALBERG KATHRYN E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 21, 2025 |
May 23, 2025 |
BLICKENSTAFF KIM D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 21, 2025 |
May 23, 2025 |
VERNON W ANTHONY
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 21, 2025 |
May 23, 2025 |
Mashal Robert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 21, 2025 |
May 23, 2025 |
Bazemore Robert B
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 2, 2025 |
May 6, 2025 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Sell |
10.0
|
-20,000
|
-62.50%
|
✓
|
$50K |
| Apr 4, 2025 |
Apr 8, 2025 |
Hung David
|
CEO |
Buy |
75.0
|
+500,000
|
0.86%
|
✗
|
$820.2K |
| Apr 1, 2025 |
Apr 3, 2025 |
Mashal Robert
|
Director |
Buy |
95.0
|
+100,000
|
100.00%
|
✗
|
$167K |
| Feb 28, 2025 |
Mar 4, 2025 |
Wentworth Kerry
|
CHIEF REGULATORY OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Sjogren Colleen
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Sauvage Philippe
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Markel Stacy
|
CHIEF PEOPLE OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Makunje Moses
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Hung David
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Hattersley Gary
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2025 |
Mar 4, 2025 |
Hanley David C.
|
CHIEF TECHNICAL OPERATIONS |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 11, 2024 |
Nov 13, 2024 |
Wang Junyuan Jerry
|
CEO |
Sell |
45.0
|
-56,361
|
-0.91%
|
✗
|
$162.9K |
| Oct 8, 2024 |
Oct 10, 2024 |
Mashal Robert
|
Director |
Buy |
95.0
|
+100,000
|
100.00%
|
✗
|
$220K |
| Oct 7, 2024 |
Oct 9, 2024 |
Sauvage Philippe
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 9, 2024 |
Sauvage Philippe
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2024 |
Sep 5, 2024 |
VERNON W ANTHONY
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2024 |
Sep 5, 2024 |
FALBERG KATHRYN E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2024 |
Sep 5, 2024 |
BLICKENSTAFF KIM D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2024 |
Sep 5, 2024 |
Bazemore Robert B
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 4, 2024 |
Sep 5, 2024 |
Wang Junyuan Jerry
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 4, 2024 |
Sep 5, 2024 |
Cui Xiangmin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 25, 2024 |
Jun 26, 2024 |
Cui Xiangmin
|
Director |
Buy |
90.0
|
+277,895
|
4.16%
|
✗
|
$825.3K |
| Jun 20, 2024 |
Jun 25, 2024 |
Cui Xiangmin
|
Director |
Buy |
95.0
|
+500,000
|
8.10%
|
✗
|
$1.5M |
| Jun 11, 2024 |
Jun 13, 2024 |
BLICKENSTAFF KIM D
|
Director |
Buy |
97.5
|
+172,189
|
100.00%
|
✗
|
$500.1K |
| May 24, 2024 |
May 29, 2024 |
WELCH DANIEL G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 9, 2024 |
Apr 11, 2024 |
Cui Xiangmin
|
Director |
Neutral |
90.0
|
+6,172,344
|
100.00%
|
✗
|
- |
|
Apr 11, 2024 |
Cui Xiangmin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 9, 2024 |
Apr 11, 2024 |
Sjogren Colleen
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 9, 2024 |
Apr 11, 2024 |
Wang Junyuan Jerry
|
CEO |
Neutral |
90.0
|
+1,929,747
|
100.00%
|
✗
|
- |
|
Apr 11, 2024 |
Wang Junyuan Jerry
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 2, 2024 |
Sjogren Colleen
|
Chief Commercial Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Wentworth Kerry
|
CHIEF REGULATORY OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Markel Stacy
|
CHIEF PEOPLE OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Makunje Moses
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Hanley David C.
|
CHIEF TECHNICAL OPERATIONS |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Hattersley Gary
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Liu Dongfang
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 29, 2024 |
Mar 4, 2024 |
Hung David
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2024 |
Jan 10, 2024 |
Mashal Robert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 10, 2024 |
Mashal Robert
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 27, 2023 |
Makunje Moses
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 19, 2023 |
Sep 22, 2023 |
NODELMAN OLEG
|
Director |
Buy |
100.0
|
+5,313,100
|
72.17%
|
✗
|
$6.7M |
| Feb 19, 2023 |
Sep 21, 2023 |
NODELMAN OLEG
|
Director |
Buy |
100.0
|
+5,313,100
|
72.17%
|
✗
|
$6.7M |
| May 15, 2023 |
May 17, 2023 |
WELCH DANIEL G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2023 |
May 17, 2023 |
VERNON W ANTHONY
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2023 |
May 17, 2023 |
FALBERG KATHRYN E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2023 |
May 17, 2023 |
BLICKENSTAFF KIM D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2023 |
May 17, 2023 |
Bazemore Robert B
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Markel Stacy
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 2, 2021 |
Mar 2, 2023 |
Hung David
|
CEO |
Neutral |
37.5
|
-368,408
|
-0.63%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Hanley David C.
|
Chief Technical Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Fox Jennifer A.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Wentworth Kerry
|
Chief Regulatory Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Liu Dongfang
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Hattersley Gary
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 30, 2022 |
Dec 5, 2022 |
FALBERG KATHRYN E
|
Director |
Buy |
97.5
|
+250,000
|
100.00%
|
✗
|
$483.8K |
| Aug 29, 2022 |
Aug 31, 2022 |
Wentworth Kerry
|
Chief Regulatory Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 29, 2022 |
Aug 31, 2022 |
Markel Stacy
|
Chief People Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 29, 2022 |
Aug 31, 2022 |
Liu Dongfang
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 29, 2022 |
Aug 31, 2022 |
Hattersley Gary
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 29, 2022 |
Aug 31, 2022 |
Hanley David C.
|
Chief Technical Operations |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 29, 2022 |
Aug 31, 2022 |
Fox Jennifer A.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2022 |
Jul 19, 2022 |
Liu Dongfang
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 19, 2022 |
Liu Dongfang
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2022 |
Jun 28, 2022 |
WELCH DANIEL G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2022 |
Jun 28, 2022 |
VERNON W ANTHONY
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2022 |
Jun 28, 2022 |
FALBERG KATHRYN E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2022 |
Jun 28, 2022 |
BLICKENSTAFF KIM D
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2022 |
Jun 28, 2022 |
Bazemore Robert B
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2022 |
May 25, 2022 |
Wentworth Kerry
|
Chief Regulatory Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 25, 2022 |
Wentworth Kerry
|
Chief Regulatory Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |